Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- HQL
- Price
- 11.48
- Stock movement up
- +0.34 (3.05%)
- Company name
- Tekla Life Sciences Investors
- Exchange
- (NYSE ,
- Currency
- USD )
- Sector
- Financial Services >Asset Management
- Market cap
- 322.14M
- Ent value
- 323.03M
- Price/Sales
- 10.19
- Price/Book
- 0.70
- Div yield
- 17.07%
- Div growth
- -4.75%
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 8.30
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -12.96%
- 3 year return
- -11.73%
- 5 year return
- -5.35%
- 10 year return
- -8.21%
Last updated: 2025-04-11
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
Dividend yield - 5y
Loading...
Dividend yield data
| Dividend per share | 1.96 |
| Dividend yield | 17.07% |
| Payout frequency | - |
| Maximum yield | 18.03% |
| Average yield | 9.87% |
| Minimum yield | 7.55% |
| Discount to avg yield | 42.20% |
| Upside potential | 73.02% |
| Yield as % of max yield | 94.69% |
Yield distribution (inverse percentile) - 5y
Loading...
Yield distribution data
| Dividend yield | 17.07% |
| Current yield distribution | 0.40% |
| Yield at 100% (Min) | 7.55% |
| Yield at 90% | 8.07% |
| Yield at 80% | 8.31% |
| Yield at 50% (Median) | 9.05% |
| Yield at 20% | 11.82% |
| Yield at 10% | 13.69% |
| Yield at 0% (Max) | 18.03% |
Dividend per share
Loading...
Dividend per share data
| Years of growth | - |
| CCC status | - |
| Dividend per share | 1.96 |
| Payout frequency | - |
| Ex-div date | 21 Feb 2025 |
| EPS (TTM) | - |
| EPS (1y forward) | - |
| EPS growth (5y) | - |
| EPS growth (5y forward) | - |
Dividend growth
Loading...
Please create a free account or log in to access this chart
Dividend growth data
| HQL | S&P500 | |
| DGR MR | 2.08% | -13.74% |
| DGR TTM | 29.69% | 6.60% |
| DGR 3 years | -6.02% | 5.24% |
| DGR 5 years | -4.75% | 5.40% |
| DGR 10 years | -0.70% | 7.07% |
| DGR 15 years | 1.16% | 6.12% |
| Time since last change announced | 249 days |
| EPS growth (5y) | - |
| EPS growth (5y forward) | - |
Payout ratio
Loading...
Please create a free account or log in to access this chart
Payout ratio data
| EPS coverage | FCF coverage | |
| TTM | - | - |
| Average | - | - |
| Forward | - | - |
Since abrdn's acquisition in 2023, HQL has delivered a total return of 25.5%, though its price appreciation has been modest. Explore more details here.
February 11, 2025
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 8.30 |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 10.19 |
| Price to Book | 0.70 |
| EV to Sales | 10.21 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 28.06M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 31.63M |
| Gross profit (TTM) | 29.04M |
| Operating income (TTM) | -12.10M |
| Net income (TTM) | 38.81M |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 91.81% |
| Operating margin (TTM) | -38.26% |
| Profit margin (TTM) | 122.69% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 1.00 |
| Net receivables | 231.11K |
| Total current assets | 1.00 |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 460.58M |
| Accounts payable | 1.79K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 0.00 |
| Total liabilities | 888.61K |
| Shareholder's equity | 459.69M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 0.00 |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | 0.00 |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 8.44% |
| Return on Assets | 8.43% |
| Return on Invested Capital | 8.44% |
| Cash Return on Invested Capital | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 11.23 |
| Daily high | 11.52 |
| Daily low | 11.14 |
| Daily Volume | 76K |
| All-time high | 41.06 |
| 1y analyst estimate | - |
| Beta | 0.70 |
| EPS (TTM) | - |
| Dividend per share | 1.96 |
| Ex-div date | 21 Feb 2025 |
| Next earnings date | 25 Jun 2025 |
Downside potential
Loading...
Downside potential data
| HQL | S&P500 | |
| Current price drop from All-time high | -72.04% | -12.89% |
| Highest price drop | -84.10% | -56.47% |
| Date of highest drop | 9 Mar 2009 | 9 Mar 2009 |
| Avg drop from high | -50.42% | -11.07% |
| Avg time to new high | 166 days | 12 days |
| Max time to new high | 6323 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
322.14M
Marketcap category
Small-cap
Description
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Employees
0
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
Tekla Life Sciences Investors is a closed end fund focused on biotechnology and pharmaceutical stocks. Read what to know about HQL here.
July 12, 2022
iO Charts is a Seeking Alpha partnerNext page